Severe Hyperferritinemia in Metabolic Dysfunction-Associated Steatotic Liver Disease With Normal Transferrin Saturation and Polyclonal Hypergammaglobulinemia Mimicking Iron Overload
Cureus · 20.05.2026
DOI: 10.7759/cureus.109279 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 20.05.2026. Verfasst von Niyas Khalid Ottu Para und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Burjeel Hospital, Abu Dhabi, ARE. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a systemic immunometabolic disorder characterized by the interplay between insulin resistance, hepatic lipid accumulation, and chronic low-grade inflammation. While mild elevations in serum ferritin are frequently observed in MASLD, markedly elevated ferritin levels often prompt evaluation for iron overload syndromes, inflammatory disorders, or malignancy. The coexistence of polyclonal hypergammaglobulinemia further complicates diagnostic interpretation. We report a 36-year-old female with overweight status, insulin resistance (homeostasis model assessment of insulin resistance (HOMA-IR) = 6.3), prediabetes (glycosylated hemoglobin = 6.1%), hypertriglyceridemia, and hyperuricemia, who demonstrated persistent hyperferritinemia (1281-1642 ng/mL) over 19 months with normal transferrin saturation (23%). Liver enzymes were mildly elevated, while bilirubin, gamma-glutamyl transferase, lactate dehydrogenase, C-reactive protein, and renal function remained normal. Serum protein electrophoresis revealed polyclonal hypergammaglobulinemia with elevated IgG. Imaging confirmed severe hepatic steatosis (S3) without fibrosis. MRI-based liver iron quantification demonstrated normal liver iron concentration (LIC = 2.70 mg/g), definitively excluding iron overload. Extensive evaluation excluded iron overload, autoimmune disease, and hematologic pathology. This case illustrates a clinically important pattern within MASLD in which hyperferritinemia reflects inflammatory signaling and iron sequestration rather than iron overload. Recognition of this phenotype enables confident diagnosis and prevents unnecessary investigations and inappropriate therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Burjeel Hospital, Abu Dhabi, ARE.
- Cardiology, Burjeel Hospital, Abu Dhabi, ARE.
- Internal Medicine, Burjeel Holdings, Abu Dhabi, ARE.
Zitieren
APA
Ottu Para, N. K., Koshy, G., & Rab, S. (2026). Severe Hyperferritinemia in Metabolic Dysfunction-Associated Steatotic Liver Disease With Normal Transferrin Saturation and Polyclonal Hypergammaglobulinemia Mimicking Iron Overload. Cureus. https://doi.org/10.7759/cureus.109279
Vancouver
Ottu Para NK, Koshy G, Rab S. Severe Hyperferritinemia in Metabolic Dysfunction-Associated Steatotic Liver Disease With Normal Transferrin Saturation and Polyclonal Hypergammaglobulinemia Mimicking Iron Overload. Cureus. 2026. doi:10.7759/cureus.109279
BibTeX
@article{OttuPara2026,
author = {Ottu Para, Niyas Khalid and Koshy, Georgey and Rab, Seema},
title = {Severe Hyperferritinemia in Metabolic Dysfunction-Associated Steatotic Liver Disease With Normal Transferrin Saturation and Polyclonal Hypergammaglobulinemia Mimicking Iron Overload},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.109279}
}
EUVIMED